Evidence map›Paper›PMID 31102120›Full record

ArticleInvestigational new drugs2020

Assessment of the cytotoxic effects of aporphine prototypes on head and neck cancer cells.

Dorival Mendes Rodrigues-Junior, Nicolie Melanie de Almeida Pontes, Gabriela Estrela de Albuquerque, Viviane Carlin, Givago Prado Perecim, Cristiano Raminelli, André Luiz Vettore

Abstract read
PubMed Publisher
In one paragraph

Article in Investigational new drugs, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Dorival Mendes Rodrigues-JuniorDepartamento de Ciências Biológicas, Campus Diadema, Universidade Federal de São Paulo, Diadema, Brazil.ORCID http://orcid.org/0000-0002-8861-9240
Nicolie Melanie de Almeida PontesLaboratório de Biologia Molecular do Câncer, Universidade Federal de São Paulo, São Paulo, Brazil.
Gabriela Estrela de AlbuquerqueDepartamento de Ciências Biológicas, Campus Diadema, Universidade Federal de São Paulo, Diadema, Brazil.
Viviane CarlinLaboratório de Biologia Molecular do Câncer, Universidade Federal de São Paulo, São Paulo, Brazil.
Givago Prado PerecimDepartamento de Química, Campus Diadema, Universidade Federal de São Paulo, Diadema, Brazil.
Cristiano RaminelliDepartamento de Química, Campus Diadema, Universidade Federal de São Paulo, Diadema, Brazil.
André Luiz VettoreDepartamento de Ciências Biológicas, Campus Diadema, Universidade Federal de São Paulo, Diadema, Brazil. andre.vettore@gmail.com.
Universidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose Among alkaloids, abundant secondary metabolites in plants, aporphines constitute a class of compounds with interesting biological activities, including anticancer effects. The present study evaluated the anticancer activities of 14 substances, including four aporphine derivatives acquired through the biomonitoring of (±)-apomorphine hydrochloride total synthesis from 2-phenethylamine and 3,4-dimethoxybenzaldehyde against head and neck squamous cell carcinoma (HNSCC). Methods The cytotoxic effects of compounds against a panel of HNSCC cell lines were determined by PrestoBlue cell viability assay, while the genotoxicity of substances was evaluated by micronucleus test. Cell death was detected by flow cytometry (Annexin V/7AAD) and western blot analysis was used to detect the presence of cleaved Caspase-3 molecules. Results The aporphine and isoquinoline derivatives APO, C1, and A5 significantly reduced HNSCC cell viability and promoted DNA damages in these cells. Further, by activating the Caspase-3 pathway, these substances were able to induce apoptosis. Conclusion Our results revealed that APO, C1, and A5 exhibit cytotoxic effects in HNSCC cells. The mechanisms of action appear to be partly via the generation of DNA damages and apoptosis induction through Caspase-3 pathway activation. This study provides preclinical data that suggest a potential therapeutic role for APO, C1, and A5 against head and neck cancer cells.

Indexed as

Antineoplastic Agents, PhytogenicApoptosisAporphinesCaspase 3Cell ProliferationHead and Neck NeoplasmsHumansSquamous Cell Carcinoma of Head and NeckTumor Cells, CulturedAntineoplastic Agents, PhytogenicAporphinesCASP3 protein, humanCaspase 3Aporphine prototypesCancer cellsCytotoxic moleculesHead and neck cancer

Identifiers

PMID31102120
OpenAlexW2945948988

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.